Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
IL8-H5217 | Human | Human IL-8 / CXCL8 Protein, premium grade |
|
||
CRS-B004 | Human | ClinMax™ Human IL-8 ELISA Kit | |||
IL8-C52H4 | Rhesus macaque | Rhesus macaque IL-8 / CXCL8 Protein, His Tag (MALS verified) |
|
||
CEA-C004 | Human | ClinMax™ Human IL-8 ELISA Kit, PRO | |||
IL8-H82H3 | Human | Biotinylated Human IL-8 protein, His,Avitag™ |
|
||
IL8-H5258 | Human | Human IL-8 / CXCL8 Protein, Fc Tag |
|
||
IL8-H52H3 | Human | Human IL-8 / CXCL8 Protein, His Tag |
|
Immobilized Rhesus macaque IL-8 / CXCL8 Protein, His Tag (Cat. No. IL8-C52H4) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human IL-8 Antibody, Human IgG1 with a linear range of 0.1-3 ng/mL (QC tested).
The purity of Rhesus macaque IL-8 Protein, His Tag (Cat. No. IL8-C52H4) is more than 85% and the molecular weight of this protein is around 14-20 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Mouse monoclonal antibody against human interleukin-8 cream | Approved | Dalian Asia Space Pharmaceutical Co Ltd, Dongguan Hongyuan Yishi Biotechnology Pharmaceutical Co Ltd | 恩博克 | Mainland China | Eczema; Psoriasis | Dalian Asia Space Pharmaceutical Co Ltd | 2001-04-10 | Psoriasis; Eczema | Details | |
Mouse monoclonal antibody against human interleukin-8 cream | Approved | Dalian Asia Space Pharmaceutical Co Ltd, Dongguan Hongyuan Yishi Biotechnology Pharmaceutical Co Ltd | 恩博克 | Mainland China | Eczema; Psoriasis | Dalian Asia Space Pharmaceutical Co Ltd | 2001-04-10 | Psoriasis; Eczema | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Post-surgical adhesions; Tissue Adhesions; Cicatrix | Details |
HuMax-IL8 | MDX-018; BMS-986253 | Phase 2 Clinical | Medarex, Genmab A/S, Bristol-Myers Squibb Company | Hematologic Neoplasms; Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular | Details |
AMY-109 | AMY-109; AMY109 | Phase 2 Clinical | Chugai Pharmaceutical Co Ltd | Solid tumours; Endometriosis | Details |
AC-701 | AC-701 | Phase 2 Clinical | Twi Pharmaceuticals Inc | Rosacea; Exanthema | Details |
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Post-surgical adhesions; Tissue Adhesions; Cicatrix | Details |
HuMax-IL8 | MDX-018; BMS-986253 | Phase 2 Clinical | Medarex, Genmab A/S, Bristol-Myers Squibb Company | Hematologic Neoplasms; Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular | Details |
AMY-109 | AMY-109; AMY109 | Phase 2 Clinical | Chugai Pharmaceutical Co Ltd | Solid tumours; Endometriosis | Details |
AC-701 | AC-701 | Phase 2 Clinical | Twi Pharmaceuticals Inc | Rosacea; Exanthema | Details |
This web search service is supported by Google Inc.